Tech Company Financing Transactions
Leversense Funding Round
Leversense, based in Newtown Square, received $300 thousand in investment from Ben Franklin Technology Partners.
Transaction Overview
Company Name
Announced On
9/30/2010
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
PO Box 60380
Newtown Square, PA 19073
USA
Newtown Square, PA 19073
USA
Phone
Website
Email Address
Overview
Leversense is currently developing next generation diagnostic biosensor technology that is extremely sensitive directly in complex matrixes such as whole blood, serum, urine, or milk.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Peter Nagy
Browse more venture capital transactions:
Prev: 9/30/2010: AeroScout venture capital transaction
Next: 9/30/2010: ProNAi Therapeutics venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from company press releases and news coverage. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs